Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CYKN SEC Suspension:
http://www.sec.gov/litigation/suspensions/2012/34-66869.pdf
ORDER:
http://www.sec.gov/litigation/suspensions/2012/34-66869-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2012/34-66870.pdf
Is this still associated with cyberkinetics or is it a shell now?
Looks recent...
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=3IG2JGuCq9XWMHDMwSIv5Q%253d%253d&nt7=0
CYKN - Some nice ask hits this morning.
$0.0070 x $0.010 on 67,500 shares traded vs. 13,496 10-day average volume.
Hi Aduke, I.'ll take a look, thanks
CYKN - 170kvs1.33k_vol10dayavg
we got some good bid support for now. just patiently waiting for a bounce up.
growmoney
Thanks, SuperC!
That's a lot of info, Harvard, MIT, 30 patents, looks like value to me, we'll see...
Since the down turn of the economy a lot of valuable IP or intellectual property be it tangible or non has been setting around collecting dust...
Maybe it's a turn
sc
Still trying to get more info.
What was the deal with The Braingate Co.?
http://www.cyberkineticsinc.com/
BrainGate™: Turning Thoughts into Action.
The concept of using thought to move a robotic device, a wheelchair, a prosthetic, or a computer was once strictly the stuff of science fiction, but no longer. BrainGate™ collects and analyzes the brainwaves of individuals with pronounced physical disabilities, turning thoughts into actions. The potential to better communicate, interact, and improve people’s way of life is about to explode.
Years of advanced research by world-renowned experts at prestigious universities—including Brown, Harvard, Emory, MIT, Columbia, and the University of Utah—has resulted in the development of BrainGate™, a life-changing technology and device that gives renewed hope to paraplegics, quadriplegics and others suffering from spinal cord injuries and strokes. Eventually, it has the potential to revolutionize the way all of our brains work.
BrainGate has been featured on broadcasts such as 60 Minutes and in publications including Popular Mechanics, Nature and Wired.
BrainGate, developer of over 30 patented technologies...
Yeah, not much to go on except dormant and a possible shell play, but that's highly speculative...
fyi
jmo
Volume slowly coming in.
They have about 17million in debt financing allocated and can continue operations for a P-1-2 and operations thru 2011. This is according to Mr. Caldwell. IMO 2011 should be a good time line to set and hold till or for that matter what ever your risk tolerances .
GLty
This sounds cool as science fiction movies are slowly coming to life, but it seems way too much liability with the trials since it is an invasive surgery. The insurance alone for this must be enough to kill this project if they don't have large amounts of money coming in.
The Company at one time was a fully reporting Company and has not filed for almost two years. the number rings and has voice mail as well. going to do more research.
The Bondholders are a big Finance biotech Company out of Boston. they represent some rather very large and real Companys.
Clinical trials.
http://www.cyberkineticsinc.com/
Clinical Trials - Now Recruiting
The purpose of the first phase of the pilot clinical study of the BrainGate2 Neural Interface System is to obtain preliminary device safety information and to demonstrate the feasibility of people with tetraplegia using the System to control a computer cursor and other assistive devices with their thoughts. Another goal of the study is to determine the participants’ ability to operate communication software, such as e-mail, simply by imagining the movement of their own hand. The study is invasive and requires surgery.
Individuals with limited or no ability to use both hands due to cervical spinal cord injury, brainstem stroke, muscular dystrophy, or amyotrophic lateral sclerosis (ALS) or other motor neuron diseases are being recruited into a clinical study at Massachusetts General Hospital (MGH). Clinical trial participants must live within a two-hour drive of Boston. Clinical trial sites at other locations may be opened in the future. The study requires a commitment of 13 months.
For more information about the study, please contact us at:
clinicaltrials@braingate2.org
Telephone: 617-726-4218 (Dr. Hochberg)
Cykn is definetly attractive at this level. it is way undervalue
congratulation. May be you can start by updating some information. Good luck
opps bidder I am in for the long run.
bedders are coming so this could test 0.005 easily
So today, they received $350K CASH, and with 50mil O/S x .002, they have a market cap of $100K. Seems like a no-brainer from here IMO
Common stock, $0.001 par value; 100,000,000 shares
authorized; 49,502,091 and 43,561,691 issued and
outstanding at June 30, 2008 and December 31, 2007,
News this AM:
NeuroMetrix Announces Acquisition of Technology and Intellectual Property Assets for Regeneration of Peripheral Nerves and Spinal Cord, and Treatment of Nervous System Injuries
WALTHAM, Mass., Jan 28, 2009 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based medical device company advancing patient care through the development and marketing of innovative products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control, announced today that it has acquired certain technological and intellectual property assets from Cyberkinetics Neurotechnology Systems, Inc. and Andara Life Science, Inc., a wholly-owned subsidiary of Cyberkinetics, for $350,000 in cash.
The acquired assets include all of Cyberkinetics' rights and regulatory filings for the Andara(TM) Oscillating Field Stimulator (OFS(TM)) technology for treatment of acute spinal cord injury, an investigational device designed to stimulate spinal cord repair and restore sensation; the rights to develop and commercialize a therapeutic product for peripheral nerve injury based on the Andara OFS neurostimulation technology; development and commercialization rights to certain derivatives of the pharmacological agent 4-aminopyridine that may be useful in the treatment of central and peripheral nervous system injury and disease; and certain other intellectual property and technology.
I'm gonna take over as Moderator, and I'll do some digging. If their relationship with Minnetronix still stands, maybe I can hop in the car. I'm in Minneapolis these days.
Today was kicked started with 2 big blocks at .001.
0.002 20000 OTO 11:17:48
0.002 5000 OTO 11:16:35
0.002 2000 OTO 10:26:15
0.0012 50000 OTO 09:35:12
0.001 200000 OTO 09:31:01
0.001 500000 OTO 09:30:55
Looks like this one may be starting up. .0007 x .002
777,000 vol
How come there are hardly any posts on this board? The only other one I know of re: CYKN is on Yahoo. Is there a better board for CYKN?
Thanks
No I have not, but I sure hope that chart closes green tomorrow.
Have you heard anything about CYKN selling off 20mil shares this month?
I sure hope so! So far it's looking pretty good.
This looks like its gonna make a HUGE move back up to dollar land!!!
Anybody on this board? CYKN has jumped up 20% in the last several days and I am hoping that Andara approval is on the way.
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
62
|
Created
|
06/01/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |